LivaNova (NASDAQ: LIVN) provided additional info regarding a cybersecurity incident first brought to light in late 2023.
In November, the company disclosed a cybersecurity breach that disrupted portions of its information technology systems and business operations. This incident came shortly after another large medtech company, Henry Schein, experienced a significant breach as well.
London-based LivaNova now says that, promptly after detecting the issues last fall, it began an investigation. That investigation enlisted external cybersecurity experts and coordinated with law enforcement. The company took action to remediate the issue, including taking certain systems offline.
The company eventually resumed manufacturing and, through the investigation, found that an unauthorized party first accessed its systems around Oct. 26, 2023.
On April 10, 2024, LivaNova discerned that the unauthorized party obtained certain identifiable personal information of U.S. patients. The company continues to analyze the nature and scope of the information. However, it said the data included information such as name, contact information (like phone number, email and postal address), Social Security number, date of birth, medical information and health insurance information.
LivaNova posted notice of the specifics of this incident on its website on April 25. It plans to notify affected U.S. patients for whom it has contact information on file. The company is offering information on how affected U.S. patients can enroll in complimentary identity protection and credit monitoring services.
In a news release, LivaNova said it encourages affected patients to remain vigilant for incidents of fraud and identity theft as a result of the breach.